Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph I Study of ACTR087 in Combo w/ SEA-BCMA in Subjects w/ Relapsed or Refractory Multiple Myeloma

Protocol: OSU-17279

Full Title

A Phase I Study of ACTR087, an Autologous T Cell Product, in Combination with SEA-BCMA, a Monoclonal Antibody, in Subjects with Relapsed or Refractory Multiple Myeloma

Multiple Myeloma